* BMSYSTEMS (BIO-MODELING) *
2004 - IDF
Key words: Models, Proof of concept, Predictive efficacy, Validation, Spin-off
Mission: to help clients run their life sciences R&D programs better, faster, cheaper and safer by applying CADI methodologies and tools, an operational systems biology approach (mainly in the fields of infectious diseases, neurology, psychiatry, oncology, dermatology and innovative bioprocesses)
Clients: R&D departments (on a partnering basis), Financers (in case of spin-off)
Age: 14 year(s)
Managing Dir.-CEO: Géa (Manuel) [co-founder, born 1960, Eng. Centrale, ex-Hemispherx (CEO), Boehringer-Ingelheim, Colgate-Palmolive, McKinsey]
Sc.Dir.-CSO: Iris (François) [also board chairman, born 1950, Ph.D., ex-Valigen (co-founder), Millenium]
Med.Dir.-CMO: Dine (Gérard) [M.D., Ph.D.]
I.T.Dir.-CIO: Santamaria (Pablo) [Eng. Centrale, ex-Formitel, Glaxo]
Financers (Hist.): privately-owned (no search for external investors)
Turnover (M€) : n.a.
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Proof-of-Concept
Company confirm : none
| 2009 .06 || Launch of BioXplain, the first open platform for Iterative, Predictive and Integrative Biology, with BioXpr (Belgium) and Kayentis (electronic pen) || MKTG || [4 years] |
| 2008 .09 || Patent : application, with CEA life Sciences, covering new therapeutic strategies and a preclinical evaluation platform for psychiatric disorders || LEGAL || [4 years] |
| 2006 .12 || Spin-off of Pherecydes (keeping minority equity) || ACQ- || [2 years] |
| 2004 .08 || Company founded by Manuel Géa, François Iris, Gérard Dine, Paul-Henri Lampe, Pablo Santamaria || ORGF || [0 year] |
Actualisation / Updating: 27-Oct-2012